Amgen Reports

Amgen (Ticker: AMGN) just reported after the bell today and it was a good quarter; not great… The company reported revenues of $3.127 billion vs. estimates of $3.34 billion. Revenues still grew a healthy 14% and EPS came in at $0.91, which beat estimates by $0.03 due to expense controls. Even though revenues came in a bit light, I still like the numbers and I think investors were expecting something worse. The stock is currently trading down a bit in after hours. Hopefully the conference call will clear up some uncertainty so the stock can trade higher.

Tomorrow, we have Genzyme (Ticker: GENZ) reporting in the morning.